Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study

被引：49
|
作者：
Stopeck, A. [1 ]
Body, J. J. [2 ]
Fujiwara, Y. [3 ]
Lipton, A. [4 ]
Steger, G. G. [5 ]
Viniegra, M. [6 ]
Fan, M. [7 ]
Braun, A. [8 ]
Dansey, R. [8 ]
Jun, S. [8 ]
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[2] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium
[3] Natl Canc Ctr, Tokyo, Japan
[4] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[5] Med Univ Vienna, Vienna, Austria
[6] Corp Med Gen San Martin, San Martin, Argentina
[7] Amgen Inc, Biostat & Epidemiol, Thousand Oaks, CA 91320 USA
[8] Amgen Inc, Hematol Oncol, Thousand Oaks, CA 91320 USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(09)72028-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2 / 3
页数：2
相关论文
共 50 条
  • [41] Zoledronic acid for the treatment of bone Metastases in patients with breast cancer and other solid tumors
    Lacerna, L
    Hohneker, J
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (05) : 150 - 160
  • [42] COMPARING THE INCIDENCE OF ACUTE PHASE REACTIONS IN PATIENTS WITH ADVANCED CANCER AND BONE METASTASES OR MULTIPLE MYELOMA FOLLOWING TREATMENT WITH DENOSUMAB OR ZOLEDRONIC ACID: RESULTS FROM A COMBINED ANALYSIS OF THREE PHASE 3 RANDOMIZED TRIALS.
    Campbell-Baird, Cynthia
    Polderdijk, Hans
    Harrelson, Stacey
    Singh, Nina
    Buechel, Judith
    Maniar, Tapan
    [J]. ONCOLOGY NURSING FORUM, 2012, 39 (03) : E178 - E179
  • [43] Number needed to treat and treatment cost per fracture avoided with denosumab compared with zoledronic acid in patients with breast cancer with bone metastases
    Wu, E. Q.
    Xie, J.
    Signorovitch, J.
    Diener, M.
    Sorg, R.
    Namjoshi, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [44] A meta-analysis of results from two randomized, double-blind studies of denosumab versus zoledronic acid (ZA) for treatment of bone metastases
    Lipton, A.
    Stopeck, A.
    von Moos, R.
    Henry, D. H.
    Richardson, G. E.
    Rodriguez, G. I.
    Bourgeois, H. P.
    Ke, C.
    Jun, S.
    Dansey, R. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] A double-blind randomized trial of Denosumab compared with Zoledronic acid for Treatment of Bone metastases in Patients with Advanced cancer (breast and prostate cancer excluded), or multiple myeloma.
    van Moos, R.
    Henry, D.
    Vadhan-Raj, S.
    Hungria, V.
    Spencer, A.
    Hirsh, V.
    Wang, J.
    Jun, S.
    Dansey, R.
    Yeh, H.
    [J]. ONKOLOGIE, 2010, 33 : 2 - 3
  • [46] Incidence of acute-phase reactions following treatment with denosumab or zoledronic acid: results from a randomized, controlled phase 3 study in patients with advanced cancer or multiple myeloma
    Polderdijk, H.
    Kofler, C.
    Wang, J.
    Sarkeshik, M.
    Yeh, H.
    [J]. EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2010, 14 : S56 - S57
  • [47] PAIN INTERFERENCE OUTCOMES IN A RANDOMIZED PHASE 3 CLINICAL TRIAL OF DENOSUMAB VS ZOLEDRONIC ACID (ZA) IN PATIENTS WITH SOLID TUMORS AND BONE METASTASES
    Cleeland, C.
    Fallowfield, L.
    von Moos, R.
    Patrick, D.
    Henry, D. H.
    Hirsh, V.
    Zarogoulidis, K.
    Feng, A.
    Cong, Z.
    Braun, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 509 - 510
  • [48] Delaying skeletal-related events in a randomized phase III study of denosumab versus zoledronic acid in patients with advanced cancer
    Henry, D. H.
    von Moos, R.
    Hungria, V.
    Costa, L.
    Woll, P. J.
    Scagliotti, G.
    Wang, J.
    Jun, S.
    Dansey, R. D.
    Yeh, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Cost-Effectiveness of Denosumab Versus Zoledronic Acid in the Management of Skeletal Metastases Secondary to Breast Cancer
    Snedecor, Sonya J.
    Carter, John A.
    Kaura, Satyin
    Botteman, Marc F.
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (06) : 1334 - 1349
  • [50] A phase III, multicenter, randomized, controlled study of maximum androgen blockade with versus without zoledronic acid in treatment-naive prostate cancer patients with bone metastases: Results of ZAPCA study.
    Kamba, Tomomi
    Kamoto, Toshiyuki
    Shimizu, Yousuke
    Namiki, Shunichi
    Fujimoto, Kiyohide
    Kawanishi, Hiroaki
    Sato, Fuminori
    Narita, Shintaro
    Satoh, Takefumi
    Saito, Hideo
    Sugimoto, Mikio
    Teishima, Jun
    Masumori, Naoya
    Egawa, Shin
    Sakai, Hideki
    Okada, Yusaku
    Terachi, Toshiro
    Ogawa, Osamu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345